Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Hepatocellular 3Liver Neoplasms 2Head and Neck Neoplasms 2Uterine Cervical Neoplasms 1Unspecified Adult Solid Tumor, Protocol Specific 1Stage III Lung Non-Small Cell Cancer AJCC v7 1Lung Neoplasms 1Liver Cirrhosis 1Hypoxia 1Gliosarcoma 1Glioblastoma 1Carcinoma, Non-Small-Cell Lung 1

Interventions

hepatitis C immune globulin, human 1fluoromisonidazole 1Weights and Measures 1Tomography, X-Ray Computed 1Tomography 1Surgical Procedures, Operative 1Shadowing Technique, Histology 1Rosuvastatin Calcium 1Radiotherapy 1Probiotics 1Positron-Emission Tomography 1Medical History Taking 1Introns 1Immunoglobulin G 1Hematologic Tests 1Furosemide 1Digoxin 1Colonoscopy 1Breath Tests 1Blood Pressure 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Liver Cirrhosis × fluoromisonidazole × Clear all
NCT02695628 2024-01-31

[18F]FMISO PET/CT After Transcatheter Arterial Embolization in Imaging Tumors in Patients With Liver Cancer

Stanford University

Phase 2 Completed
5 enrolled 8 charts
Gastrointestinal

Carcinoma, Hepatocellular, Liver Cirrhosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡